E Point Perfect

San Diego’s Illumina Challenges European Order to Keep Grail Separate


Illumina campus in San Diego
A sign on Illumina’s campus in San Diego. Reuters/Mike Blake

San Diego-based DNA sequencing company Illumina on Tuesday challenged an EU antitrust order to keep cancer screening firm Grail separate, ratcheting up its fight against EU regulators which blocked a merger deal last year.

Following its veto, the European Union competition enforcer renewed an interim measure last October requiring Illumina to keep Grail as a separate entity so the company can unwind a takeover it had completed without waiting for the deal to get EU approval.

“Today, we appealed the European Commission’s interim measures order to hold separate Illumina and Grail,” Illumina said in a statement.

“We disagree that the Commission has jurisdiction to review the merger, and with the premise of the interim measures itself and with a number of its provisions, the Commission has exceeded its authority,” it said.

The EU executive said in emailed comment it would defend its case in court.

Illumina has three appeals pending in the Luxembourg courts, Europe’s top courts, against the EU enforcer’s ruling that it jumped the gun by closing the deal without securing approval, the EU’s subsequent veto and the EU decision to examine the case.


Source link

Related posts

Homes Flooded After Early Morning Water Main Break in South Bay Area

Tom York on Business: Despite National Slowdown, Apartment Rents Still Rising in San Diego

First Asylum Seekers Cross into U.S. from Mexico Using New CBP Mobile App

Authorities Seek Tips in El Cajon Crest-Area Residential Burglary

Teen Pleads Not Guilty to Murder in 15-Year-Old’s Lemon Grove Shooting

Buried Treasure: California Politicians Stash $35 Million in Leftover Campaign Funds